Gossamer Bio EPS Basic from Accounting Change (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.74 +0.14 (+5.38%) USD | NASDAQ | Jan 21, 16:00

2.83 +0.09 (+3.28%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	--
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	--